MSAC consultations

The Medical Services Advisory Committee (MSAC) meets 3 times a year to assess applications of new medical services. For most items being considered there are 2 consultation periods: prior to the PICO Advisory Sub-Committee (PASC) meeting, and prior to the MSAC meeting.

Learn more about the MSAC and the Medicare Benefits Schedule (MBS).

Open MSAC consultations

Listed below and via the ‘show more’ button are open consultations for items being considered by the MSAC.

MSAC Consultation Survey - Application 1823

MSAC application 1823 177 Lutetium PSMA-617 for prostate specific membrane antigen (PSMA)-positive, taxane-naïve patients with metastatic castrate resistant prostate cancer (mCRPC). ...

More

MSAC Consultation Survey - Application 1802

MSAC application 1802 - Supervised oral food challenge (OFC) in patients with suspected food allergy. Consultation is open on applications for consideration by the Medical Services...

More

MSAC Consultation Survey - Application 1815

MSAC application 1815 Computed tomography (CT) of the coronary arteries to determine coronary artery calcium score. Consultation is open on applications for consideration by the...

More

MSAC Consultation Survey - Application 1822

MSAC application 1822 F-18 Fluorodeoxyglucose (FDG) positron emission tomography (PET) for evaluation of complex infection. Consultation is open on applications for consideration by...

More

MSAC Consultation Survey - Application 1831

MSAC Application 1831 Kappa free-light chain (kFLC) index testing for the diagnosis of multiple sclerosis (MS). Consultation is open on applications for consideration by the Medical...

More

MSAC Consultation Survey - Application 1832

MSAC Application 1832 Detection of measurable residual disease (MRD) in patients with multiple myeloma (MM). Consultation is open on applications for consideration by the Medical...

More

MSAC Consultation Survey - Application 1830

MSAC application 1830 Genetic testing to identify homologous recombination repair (HRR) gene alterations in patients with metastatic castration-sensitive prostate cancer (mCSPC) to determine...

More

MSAC Consultation Survey - Application 1829

MSAC application 1829 Anti-Müllerian hormone testing for identification of Polycystic Ovarian Morphology, to support the diagnosis of Polyendrocrine Metabolic Ovarian Syndrome (PMOS). ...

More

MSAC Consultation Survey - Application 1828

MSAC application 1828 Review of devices used in catheter-based cardiac ablation for the treatment of patients with cardiac arrhythmias. Consultation is open on applications for...

More
Show more

MSAC Updates

Subscribe to MSAC email bulletins on the MSAC meeting agendas and consultations, and important updates.

Sign up